title: Reply to: 'Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity' by Kern et al.
authors.forename: U
authors.initials: U
authors.lastname: Oelschlaegel
authors.forename: B
authors.initials: B
authors.lastname: Mohr
authors.forename: M
authors.initials: M
authors.lastname: Schaich
authors.forename: F
authors.initials: F
authors.lastname: Kroschinsky
authors.forename: S
authors.initials: S
authors.lastname: Parmentier
authors.forename: M
authors.initials: M
authors.lastname: Bornhäuser
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
authors.forename: C
authors.initials: C
authors.lastname: Thiede
mesh_terms: D000328:Adult; D000368:Aged; D002454:Cell Differentiation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D000090243:Nucleophosmin; D011379:Prognosis; D011446:Prospective Studies
chemical_list: C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin